Table 2.
Item | Information the radiologist should know but should not be necessarily included in the report | Agreement (median) | Consensus (IQR) |
---|---|---|---|
Staging |
- Histotype of the tumor, if provided by the biopsy (Lauren / WHO); - Relevant clinical symptoms (bleeding, occlusion, etc.); - Previous cancer history, if present, and related stage of disease; - If the patient suffers from one of the following pathologies: FAP, Li-Fraumeni, HNPCC, Peutz-Jeghers, HDGC; - Cardiovascular comorbidity |
8 | 2 |
Restaging |
- Number of chemotherapy cycles and date of the last cycle; - Extraparietal extension of the primary tumor if documented through laparoscopy; - Type of laparoscopic procedure performed (e.g., retrocavity opening, peritoneal biopsies); - Results of any peritoneal biopsies; - Results of peritoneal lavage, if performed; |
8 | 1,5 |
Follow-up |
- Histotype of the neoplasm (Lauren / WHO) - TRG according to Becker and/or Mandard; - Any post-surgical complications; - Results of peritoneal lavage; - Basal tumor markers (CA 19.9, CEA) - Tumor markers on the date of the follow-up examination - Residual tumor indicator (especially if R0); - Previous/other oncological pathology and its stage; - If cholecystectomy and/or splenectomy is performed; - If omentectomy is performed; - If peritonectomy and/or HIPEC is performed; |
9 | 1 |